Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Camurus AB (CAMRF)
OTHER OTC:CAMRF
Holding CAMRF?
Track your performance easily
CAMRF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$21.81 - $73.25
Previous Close$56
Volume204.00
Average Volume (3M)200.00
Market Cap
$3.30B
Enterprise Value$3.25B
Total Cash (Recent Filing)kr565.54M
Total Debt (Recent Filing)kr26.22M
Price to Earnings (P/E)151.6
Beta0.65
Next Earnings
Nov 07, 2024EPS Estimate
$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.37
Shares OutstandingN/A
10 Day Avg. Volume46
30 Day Avg. Volume200
Standard Deviation0.30
R-Squared0.21
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)13.62
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$70.61Price Target Upside23.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Camurus AB News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.54% Mutual Funds
― Other Institutional Investors
95.41% Public Companies and
Individual Investors
CAMRF FAQ
What was Camurus AB’s price range in the past 12 months?
Camurus AB lowest stock price was $21.81 and its highest was $73.25 in the past 12 months.
What is Camurus AB’s market cap?
Currently, no data Available
When is Camurus AB’s upcoming earnings report date?
Camurus AB’s upcoming earnings report date is Nov 07, 2024 which is in 5 days.
How were Camurus AB’s earnings last quarter?
Camurus AB released its earnings results on Jul 16, 2024. The company reported $0.118 earnings per share for the quarter, missing the consensus estimate of $0.139 by -$0.021.
Is Camurus AB overvalued?
According to Wall Street analysts Camurus AB’s price is currently Undervalued.
Does Camurus AB pay dividends?
Camurus AB does not currently pay dividends.
What is Camurus AB’s EPS estimate?
Camurus AB’s EPS estimate is $0.15.
How many shares outstanding does Camurus AB have?
Camurus AB has 58,808,770 shares outstanding.
What happened to Camurus AB’s price movement after its last earnings report?
Camurus AB reported an EPS of $0.118 in its last earnings report, missing expectations of $0.139. Following the earnings report the stock price went up 1.706%.
Which hedge fund is a major shareholder of Camurus AB?
Currently, no hedge funds are holding shares in CAMRF
---
Camurus AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
156.76%
12-Months-Change
Fundamentals
Return on Equity
10.38%
Trailing 12-Months
Asset Growth
97.37%
Trailing 12-Months
Company Description
Camurus AB
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer and endocrine diseases. The company has Europe, North America and Other geographical areas geographic segments. It derives the majority of its revenues from North America geographic segment. The company's product pipeline includes CAM2038, CAM2029, CAM2032 product candidates.
---
CAMRF Company Deck
---
CAMRF Earnings Call
Q2 2024
0:00 / 0:00
---
CAMRF Stock 12 Month Forecast
Average Price Target
$70.61
▲(23.88% Upside)
Technical Analysis
Best Analysts Covering CAMRF
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
+45.37%
reiterated a buy rating 19 days ago
Copying Brian Balchin's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +45.37% per trade.
---